Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

106.84
+5.855.79%
Volume:1.09M
Turnover:115.52M
Market Cap:6.21B
PE:-32.55
High:107.84
Open:104.13
Low:102.24
Close:100.99
52wk High:130.23
52wk Low:73.16
Shares:58.08M
Float Shares:55.40M
Volume Ratio:1.51
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2819
EPS(LYR):-3.2819
ROE:-26.38%
ROA:-5.80%
PB:9.46
PE(LYR):-32.55

Loading ...

Glaukos sees FY26 revenue $600M-$620M, consensus $613.35M

TIPRANKS
·
Feb 18

Glaukos posts Q4 net revenues of USD 143.1 million, up 36%

Reuters
·
Feb 18

Glaukos Q4 Adj. EPS $(0.28) Misses $(0.20) Estimate, Sales $143.100M Beat $136.396M Estimate

Benzinga
·
Feb 18

BRIEF-Glaukos Q4 Adjusted Net Income USD -16.4 Million Vs. IBES Estimate USD -12.1 Million

Reuters
·
Feb 18

Glaukos Corp: Q4 Adj Loss per Share $0.28

THOMSON REUTERS
·
Feb 18

Glaukos Q4 Net Income USD -133.7 Million

THOMSON REUTERS
·
Feb 18

Glaukos Q4 Adjusted Gross Margin 85%

THOMSON REUTERS
·
Feb 18

Glaukos Corp: Reaffirmed 2026 Net Sales Guidance of $600 Mln to $620 Mln

THOMSON REUTERS
·
Feb 18

Analysts Offer Insights on Healthcare Companies: Glaukos (GKOS) and Avantor (AVTR)

TIPRANKS
·
Feb 11

Earning Preview: Glaukos Q4 revenue is expected to increase by 35.42%, and institutional views are broadly bullish

Earnings Agent
·
Feb 10

Glaukos assumed with an Outperform at William Blair

TIPRANKS
·
Jan 30

Glaukos Is Maintained at Buy by BTIG

Dow Jones
·
Jan 29

Glaukos price target raised to $131 from $123 at BTIG

TIPRANKS
·
Jan 29

Wells sees potential upside after Glaukos’ iDose repeat dosing label approved

TIPRANKS
·
Jan 28

Glaukos Corp : Btig Raises Target Price to $131 From $123

THOMSON REUTERS
·
Jan 28

BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International

Reuters
·
Jan 28

Shares of Glaukos Rise 4.2% Premarket After FDA Allows Repeat Use of Glaucoma Implant

THOMSON REUTERS
·
Jan 28

BUZZ-Glaukos rises as FDA allows repeat use of glaucoma implant

Reuters
·
Jan 28

FDA Approves Glaukos Labeling Supplement Allowing iDose TR Re-Administration

Reuters
·
Jan 28

Glaukos Corp - Idose Tr Shows Favorable Long-Term Corneal Safety Profile

THOMSON REUTERS
·
Jan 28